HomeCompareNH vs PLD

NH vs PLD: Dividend Comparison 2026

NH yields 148.15% · PLD yields 3.18%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 NH wins by $16.95M in total portfolio value
10 years
NH
NH
● Live price
148.15%
Share price
$1.35
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$23.46M
Annual income
$10,076,148.54
Full NH calculator →
PLD
PLD
● Live price
3.18%
Share price
$128.78
Annual div
$4.10
5Y div CAGR
74.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$6.50M
Annual income
$5,256,436.18
Full PLD calculator →

Portfolio growth — NH vs PLD

📍 NH pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodNHPLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, NH + PLD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
NH pays
PLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NH
Annual income on $10K today (after 15% tax)
$12,592.59/yr
After 10yr DRIP, annual income (after tax)
$8,564,726.26/yr
PLD
Annual income on $10K today (after 15% tax)
$270.62/yr
After 10yr DRIP, annual income (after tax)
$4,467,970.75/yr
At 15% tax rate, NH beats the other by $4,096,755.51/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NH + PLD for your $10,000?

NH: 50%PLD: 50%
100% PLD50/50100% NH
Portfolio after 10yr
$14.98M
Annual income
$7,666,292.36/yr
Blended yield
51.18%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PLD right now

NH
Analyst Ratings
6
Buy
Consensus: Buy
Altman Z
-13.1
Piotroski
3/9
PLD
Analyst Ratings
25
Buy
16
Hold
1
Sell
Consensus: Buy
Price Target
$136.00
+5.6% upside vs current
Range: $119.00 — $155.00
Altman Z
1.9
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NH buys
0
PLD buys
0
No recent congressional trades found for NH or PLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricNHPLD
Forward yield148.15%3.18%
Annual dividend / share$2.00$4.10
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%74.4%
Portfolio after 10y$23.46M$6.50M
Annual income after 10y$10,076,148.54$5,256,436.18
Total dividends collected$21.69M$6.37M
Payment frequencyquarterlyquarterly
SectorStockREIT
Analyst consensusBuyBuy

Year-by-year: NH vs PLD ($10,000, DRIP)

YearNH PortfolioNH Income/yrPLD PortfolioPLD Income/yrGap
1← crossover$25,515$14,814.81$11,255$555.24+$14.3KNH
2$62,628$35,326.85$13,062$1,018.59+$49.6KNH
3$148,051$81,039.20$15,903$1,926.67+$132.1KNH
4$337,457$179,042.34$20,839$3,823.32+$316.6KNH
5$742,477$381,398.70$30,464$8,166.08+$712.0KNH
6$1,578,712$784,260.93$52,054$19,457.30+$1.53MNH
7$3,247,684$1,558,462.68$109,886$54,188.93+$3.14MNH
8$6,471,310$2,996,288.20$304,030$186,451.18+$6.17MNH
9$12,504,097$5,579,794.89$1,166,125$840,813.32+$11.34MNH
10$23,455,532$10,076,148.54$6,504,190$5,256,436.18+$16.95MNH

NH vs PLD: Complete Analysis 2026

NHStock

NantHealth, Inc., together with its subsidiaries, operates as a healthcare IT company in the United States, Canada, and the United Kingdom. It offers Eviti, a software-as-a-service (SaaS) based clinical decision support solution that centralizes clinical content and treatment cost data from Medicare reimbursements and treatment toxicity data; Eviti Connect, which utilizes the platform to offer pre-authorization automation that helps payers and providers navigate the complexities of cancer care; and Eviti Advisor product that allows physicians to access the Eviti platform's comprehensive library of evidence-based treatment standards and protocols to inform treatment decisions. The company also provides NaviNet, a suite of SaaS-based solution enabling payers and providers to streamline communication and consolidate information; NaviNet Open, a payer-provider collaboration platform for communication between health plans and providers; NaviNet AllPayer that provides eligibility, benefit, and claim status information to provider offices for commercial and government plans and CMS for Medicare beneficiaries through the NaviNet portal; and OpenNMS is an open-source network monitoring solution for enterprise-grade networks. In addition, it offers Quadris, a data solution that includes multi-data analysis, reporting, and professional services. The company was formerly known as Nant Health, LLC and changed its name to NantHealth, Inc. in June 2016. The company was incorporated in 2010 and is headquartered in Morrisville, North Carolina. NantHealth, Inc. is as a subsidiary of NantWorks, LLC.

Full NH Calculator →

PLDREIT

Prologis, Inc. is the global leader in logistics real estate with a focus on high-barrier, high-growth markets. As of December 31, 2020, the company owned or had investments in, on a wholly owned basis or through co-investment ventures, properties and development projects expected to total approximately 984 million square feet (91 million square meters) in 19 countries. Prologis leases modern logistics facilities to a diverse base of approximately 5,500 customers principally across two major categories: business-to-business and retail/online fulfillment.

Full PLD Calculator →
📬

Get this NH vs PLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NH vs SCHDNH vs JEPINH vs ONH vs KONH vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.